Restrictive Cardiomyopathy (RCM)

Restrictive Cardiomyopathy, also known as familial restrictive cardiomyopathy, is related to cardiomyopathy, familial restrictive, 1 and cardiomyopathy, familial restrictive, 2. An important gene associated with Restrictive Cardiomyopathy is TNNI3 (Troponin I3, Cardiac Type), and among its related pathways/superpathways are Cardiac conduction and Cytoskeletal Signaling. The drug Hydroxyurea has been mentioned in the context of this disorder. Affiliated tissues include heart and lung, and related phenotypes are muscle and cardiovascular system